Quantum BioPharma Ltd. (QNTM) has a negative trailing P/E of -0.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -196.07%.
Criteria proven by this page:
Overall SharesGrow Score: 36/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -3,830.2 | 408.55 | -2,090.04 | 0.00 | - |
| 2017 | -40.5 | 0.00 | 11.50 | 5,500.91 | - |
| 2018 | -15.2 | -0.03 | 6.78 | 0.00 | - |
| 2019 | -1.0 | -0.01 | 1.06 | 0.00 | - |
| 2020 | -0.6 | 0.01 | 0.52 | 0.00 | - |
| 2021 | -1.0 | 0.02 | 0.66 | 0.00 | - |
| 2022 | -1.3 | 0.03 | 1.00 | 0.00 | - |
| 2023 | -2.0 | 0.08 | 2.75 | 0.00 | - |
| 2024 | -0.3 | 0.01 | 0.36 | 0.00 | - |
| 2025 | -0.9 | 0.03 | 3.47 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.29 | $0.00 | $-29.63K | - |
| 2017 | $-27.75 | $20.63K | $-2.8M | -13586% |
| 2018 | $-183.54 | $0.00 | $-16.67M | - |
| 2019 | $-360.45 | $0.00 | $-39.13M | - |
| 2020 | $-171.62 | $0.00 | $-31.8M | - |
| 2021 | $-65.63 | $0.00 | $-35.29M | - |
| 2022 | $-39.62 | $0.00 | $-23.61M | - |
| 2023 | $-29.39 | $0.00 | $-17.9M | - |
| 2024 | $-12.49 | $0.00 | $-14.2M | - |
| 2025 | $-8.11 | $0.00 | $-26.63M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-3.71 | $-3.71 – $-3.71 | $14.96M | $14.96M – $14.96M | 1 |
| 2027 | $0.00 | $0.00 – $0.00 | $26.02M | $26.02M – $26.02M | 0 |
| 2028 | $0.00 | $0.00 – $0.00 | $48.07M | $48.07M – $48.07M | 0 |
| 2029 | $0.00 | $0.00 – $0.00 | $262.57M | $262.57M – $262.57M | 0 |
